UKRI Translation: MRC Impact Acceleration Awards

Résumé

This call from the Medical Research Council (MRC) funds projects to address a single, high-risk development step and generate key data to de-risk new medicines, medical devices, diagnostics, or other medical products. Applicants must be based at a research organisation eligible for MRC funding. The application deadline is 11 November 2026.

This MRC call is focused on medical research translation (medicines, medical devices, diagnostics) and explicitly requires applicants to be based at research organisations eligible for MRC funding. Acme Corporation, a semiconductor and AI company, does not match the medical/life sciences domain, and as a commercial entity would not typically qualify for MRC funding designed for academic and research institutions.

Scores détaillés

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

Apply to the MRC Impact Acceleration Award to address a single, high-risk development step and generate key data to de-risk a new medicine, medical device, diagnostic or other medical product. You must be based at a research organisation eligible for MRC funding.